The Ophthalmic Devices Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increased Emphasis on Customer Training and Education on Eye Illnesses Among Eye Care Professionals
The rising frequency of ocular illnesses such as cataracts and glaucoma is a primary driver of the global ophthalmic devices industry. Increased emphasis on customer training and education about eye diseases and associated complications among eye care professionals, as well as increased penetration of digital devices such as laptops, smartphones, computers, and e-readers; rapid technological advancements such as the introduction of intraocular lenses (IOLs); Furthermore, the market is predicted to grow as a consequence of increasing R&D activity for breakthrough vision-related technologies and improved awareness of ophthalmic equipment.
High Prevalence of Ophthalmic Diseases such as Cataract and Glaucoma Continues
Cataracts and glaucoma are very prevalent ageing adverse effects. Many persons over the age of 60 will most likely have both. Otherwise, no link exists between the two. A cataract is a vision-impairing eye condition in which cloudiness or opacity in the lens limits or modifies light penetration, causing vision to be impaired.
Glaucoma is a group of eye diseases that slowly deprive people of their eyesight. Vision loss is caused by damage to the optic nerve. Cataracts and glaucoma are two serious eye illnesses that cause vision loss. Cataract-related vision loss, on the other hand, can be restored with surgery. The eyesight loss caused by glaucoma is now irreversible.
What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the ophthalmic devices market evolving?
• What is driving and restraining the ophthalmic devices market?
• How will each ophthalmic devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each ophthalmic devices submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading ophthalmic devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the ophthalmic devices projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implication of ophthalmic devices projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the ophthalmic devices market?
• Where is the ophthalmic devices market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?
You need to discover how this will impact the ophthalmic devices market today, and over the next 10 years:
• Our 580-page report provides 351 tables and 339 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the ophthalmic devices market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising ophthalmic devices prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.
Segments Covered in the Report
Optical Coherence Tomography Type
• Perimeters
• Slit Lamps
• Tonometer
Ophthalmic Diagnostic Devices
• Refractors
• Corneal Topography Systems
• Retinal Ultrasound Systems
• Fundus Camera
• Ophthalmoscopes
• Other Ophthalmic Diagnostic Devices
Type
• Ophthalmic Surgical Devices
• Ophthalmic Diagnostic Devices
• Optical Coherence Tomography Systems
• Ophthalmic Vision Care Devices
• Contact Lenses
• Spectacle Lenses
Ophthalmic Surgical Devices
• Refractive Error Surgical Devices
• Glaucoma Surgical Devices
• Cataract Surgery Devices
• Vitreoretinal Surgical Devices
End-User
• Hospitals
• Diagnosis Clinics
• Franchise Optical Stores
• Eye Research Institutes
• Government Agencies
• Academics
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
• LAMEA
• Brazil
• Turkey
• Saudi Arabia
• South Africa
• UAE
• Rest of Latin America
The report also includes profiles and for some of the leading companies in the Ophthalmic Devices Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Alcon AG
• Bausch Health Companies Inc
• Carl Zeiss Meditec
• Essilor Luxottica
• Glaukos Corporation
• Gulden Ophthalmics
• Haag-Streit Company
• Heine Optotechnik
• HOYA Corporation
• Johnson & Johnson Vision Care
• Lumenis
• NIDEK
• Novartis AG
• OPHTEC BV
• Sonomed Escalon Medical Corp.
• STAAR Surgical
• The Cooper Companies, Inc.
• Topcon
• Visionix
• Ziemer Ophthalmic Systems
Overall world revenue for Ophthalmic Devices Market, 2022 to 2032 in terms of value the market will surpass US$60,588 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Ophthalmic Devices Market, 2022 to 2032 Market report helps you?
In summary, our 580-page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Ophthalmic Devices Market, 2022 to 2032 Market, with forecasts for Optical Coherence Tomography Type, Ophthalmic Diagnostic Devices, Type, Ophthalmic Surgical Devices, End-users each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for 4 regional and 20 key national markets – See forecasts for the Ophthalmic Devices Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 20 of the major companies involved in the Ophthalmic Devices Market, 2022 to 2032 Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Ophthalmic Devices Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.
'
1. Report Overview
1.1 Introduction to Ophthalmic Devices Market
1.2 Global Ophthalmic Devices Market Overview
1.3 What are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Why You Should Read This Report
1.6 What This Report Delivers
1.7 Key Questions Answered By This Analytical Report Include:
1.8 Who is This Report for?
1.9 Research Methodology
1.9.1 Primary Research
1.9.2 Secondary Research
1.9.3 Market Evaluation & Forecasting Methodology
1.10 Frequently Asked Questions (FAQs)
1.11 Associated Reports
1.12 About
2 Executive Summary
3 Global Market Dynamics
3.1 Covid-19 Impact On The Ophthalmic Devices Market
3.2 Current Trends in the Ophthalmic Devices Market
3.3 Market Driving Factors
3.3.1 Increase In Prevalence Of Ophthalmic Diseases Such As Cataract And Glaucoma
3.3.2 Rising Prevalence Of Eye Diseases
3.3.2.1 Errors in Refraction
3.3.2.2 Macular Degeneration as a Result of Growing Older
3.3.2.3 Cataracts
3.3.2.4 Diabetic Retinopathy is a condition that occurs when a person has diabetes.
3.3.2.5 Glaucoma
3.3.3 Increase In Number Of People Suffering From Ophthalmic Disorders
3.3.4 Technological Advancements
3.3.4.1 Cataract surgery
3.3.4.2 Newer Technologies For Refractive Surgery
3.3.5 Rising Adoption Of Contact Lenses And Spectacles
3.3.6 Increasing Government Initiatives To Boost Market Growth
3.3.7 Growing Preference For Minimally Invasive Surgeries
3.3.7.1 Microtrabeculectomies
3.3.7.2 Trabecular Surgery
3.3.7.3 Suprachoroidal Shunts
3.3.7.4 New Laser Procedures
3.3.8 Rising Geriatric Population Projected To Fuel Market Growth
3.4 Market Restraining Factors
3.4.1 High Costs Of Ophthalmology Devices
3.4.2 Side Effects Of Cosmetic Eye Surgery
3.4.2.1 Soreness:
3.4.2.2 Light sensitivity:
3.4.2.3 Complications:
3.4.3 Lack Of Skilled Professionals
3.5 Opportunities in the Global Market
3.5.1 Consolidation And Private Equity In Eye Care
3.5.2 The Rise Of Specialty Care
3.5.3 Demand For Eye Care Services
3.5.4 Untapped Potential Of Emerging Markets
3.6 Challenges in the Global Market
3.6.1 Lack Of Awareness, Low Access To Eye Care In Low-Income Economies
3.6.2 Infection Control For Ophthalmologists
3.7 SWOT Analysis
3.7.1 Strength
3.7.1.1 Increase In Prevalence Of Ophthalmic Diseases Such As Cataract And Glaucoma
3.7.1.2 Rising Prevalence Of Eye Diseases
3.7.1.3 Technological Advancements
3.7.1.4 Rising Adoption Of Contact Lenses And Spectacles
3.7.1.5 Increasing Government Initiatives To Boost Market Growth
3.7.1.6 Rising Geriatric Population Projected To Fuel Market Growth
3.7.2 Weakness
3.7.2.1 High Costs Of Ophthalmology Devices
3.7.2.2 Side Effects Of Cosmetic Eye Surgery
3.7.2.3 Lack Of Skilled Professionals
3.7.3 Opportunities
3.7.3.1 Consolidation And Private Equity In Eye Care
3.7.3.2 The Rise Of Specialty Care
3.7.3.3 Demand For Eye Care Services
3.7.3.4 Untapped Potential Of Emerging Markets
3.7.4 Threats
3.7.4.1 Lack Of Awareness, Low Access To Eye Care In Low-Income Economies
3.7.4.2 Infection Control For Ophthalmologists
3.8 Porter’s Five Forces
3.8.1 Competitive Rivalry
3.8.2 Bargaining Power of Buyers
3.8.3 Bargaining Power of Suppliers
3.8.4 Threat of Substitutes
3.8.5 The Threat Of New Entrants
3.9 PEST Analysis
3.9.1 Political Factor
3.9.2 Economical Factor
3.9.3 Social Factor
3.9.4 Technological Factor
4 Global Ophthalmic Devices Market Analysis
4.1 Global Market Outlook
4.2 Global Market Size Estimation and Forecast
4.2.1 Pre-COVID-19 Market Scenario
4.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5 Global Ophthalmic Devices Market Analysis By Region
5.1 North America
5.2 Europe
5.3 Asia Pacific
5.4 LAMEA
5.5 Regional Market Size Estimation and Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Ophthalmic Devices Market Analysis By Optical Coherence Tomography Type
6.1 Perimeters
6.2 Slit Lamps
6.3 Tonometer
6.4 Global Market Size Estimation and Forecast By Optical Coherence Tomography Type
6.4.1 Pre-COVID-19 Market Scenario
6.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Ophthalmic Devices Market Analysis By Ophthalmic Diagnostic Devices
7.1 Refractors
7.2 Corneal Topography Systems
7.3 Retinal Ultrasound Systems
7.4 Fundus Camera
7.5 Ophthalmoscopes
7.6 Other Ophthalmic Diagnostic Devices
7.7 Global Market Size Estimation and Forecast By Ophthalmic Diagnostic Devices
7.7.1 Pre-COVID-19 Market Scenario
7.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Ophthalmic Devices Market Analysis By Type
8.1 Ophthalmic Surgical Devices
8.1.1.1 Choosing Surgical Forceps
8.1.1.2 Hooks & Probes
8.1.1.3 Micro Scissors
8.1.1.4 Needle Holders
8.2 Ophthalmic Diagnostic Devices
8.3 Optical Coherence Tomography Systems
8.4 Contact Lenses
8.5 Spectacle Lenses
8.6 Global Market Size Estimation and Forecast By Type
8.6.1 Pre-COVID-19 Market Scenario
8.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Ophthalmic Devices Market Analysis By Ophthalmic Surgical Devices
9.1 Refractive Error Surgical Devices
9.2 Glaucoma Surgical Devices
9.3 Cataract Surgery Devices
9.4 Vitreoretinal Surgical Devices
9.5 Global Market Size Estimation and Forecast By Ophthalmic Surgical Devices
9.5.1 Pre-COVID-19 Market Scenario
9.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Global Ophthalmic Devices Market Analysis By End-User
10.1 Hospitals
10.2 Diagnosis Clinics
10.3 Franchise Optical Stores
10.4 Eye Research Institutes
10.5 Government Agencies
10.6 Academics
10.7 Global Market Size Estimation and Forecast By End-User
10.7.1 Pre-COVID-19 Market Scenario
10.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 North America Ophthalmic Devices Market Analysis
11.1 Rising Prevalence of Eye Diseases Is Driving the North American Market
11.2 North America Market Size Estimation and Forecast
11.2.1 Pre-COVID-19 Market Scenario
11.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.3 Country Market Size Estimation and Forecast
11.3.1 Pre-COVID-19 Market Scenario
11.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.4 North America Market Size Estimation and Forecast By Optical Coherence Tomography Type
11.4.1 Pre-COVID-19 Market Scenario
11.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.5 North America Market Size Estimation and Forecast By Ophthalmic Diagnostic Devices
11.5.1 Pre-COVID-19 Market Scenario
11.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.6 North America Market Size Estimation and Forecast By Type
11.6.1 Pre-COVID-19 Market Scenario
11.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.7 North America Market Size Estimation and Forecast By Ophthalmic Surgical Devices
11.7.1 Pre-COVID-19 Market Scenario
11.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.8 North America Market Size Estimation and Forecast By End-User
11.8.1 Pre-COVID-19 Market Scenario
11.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.9 U.S. Ophthalmic Devices Market Analysis
11.9.1 Ophthalmic Sciences Unveils AI Contactless Device For Measuring Eye Fluid Pressure
11.9.2 NTC And I-MED Pharma Form Strategic Partnership To Bring The Leading HA-Based Dry Eye Ointment To The United States Market
11.9.3 Pre-COVID-19 Market Scenario
11.9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.10 Canada Ophthalmic Devices Market Analysis
11.10.1 FDA Approves Bausch + Lomb Clearvisc™ Dispersive Ophthalmic Viscosurgical Device
11.10.2 Sun Pharma Launches Dry Eye Treatment Product In Canada
11.10.3 Pre-COVID-19 Market Scenario
11.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.11 Mexico Ophthalmic Devices Market Analysis
11.11.1 Contact Lenses Segment Is Expected To Hold A Major Share In The Studied Market
11.11.2 Pre-COVID-19 Market Scenario
11.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 Europe Ophthalmic Devices Market Analysis
12.1 European Ophthalmology Drug And Device Market Is Expected To Witness Significant Growth
12.2 Europe Market Size Estimation and Forecast
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Country Market Size Estimation and Forecast
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 Europe Market Size Estimation and Forecast By Optical Coherence Tomography Type
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 Europe Market Size Estimation and Forecast By Ophthalmic Diagnostic Devices
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 Europe Market Size Estimation and Forecast By Type
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 Europe Market Size Estimation and Forecast By Ophthalmic Surgical Devices
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 Europe Market Size Estimation and Forecast By End-User
12.8.1 Pre-COVID-19 Market Scenario
12.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 Germany Ophthalmic Devices Market Analysis
12.9.1 ZEISS Introduces A Series Of Major Innovations And Industry-First Software Applications As Part Of The ZEISS Medical Ecosystem
12.9.2 Singaporean POC Telemedc Forms R&D Partnership With German UKE Center Through Scaler8
12.9.3 Pre-COVID-19 Market Scenario
12.9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 UK Ophthalmic Devices Market Analysis
12.10.1 UK Medtech Firm Raises Over $2.29m To Deliver Ophthalmic Devices
12.10.2 Experts Develop Novel Intraocular Lenses Providing Full Range Of Vision
12.10.3 Pre-COVID-19 Market Scenario
12.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 France Ophthalmic Devices Market Analysis
12.11.1 France's Abionyx To Buy IRIS Pharma Holding, Expand Into Ophthalmology
12.11.2 Pre-COVID-19 Market Scenario
12.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 Italy Ophthalmic Devices Market Analysis
12.12.1 Topcon Acquires VISIA Imaging S.R.L, Ophthalmic Medical Device Manufacturer In Italy
12.12.2 SIFI Introduces SYNFO To Treat Dry Eye Disease
12.12.3 Pre-COVID-19 Market Scenario
12.12.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.13 Spain Ophthalmic Devices Market Analysis
12.13.1 Ocular Related Emergencies In Spain During The COVID-19 Pandemic
12.13.2 Pre-COVID-19 Market Scenario
12.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.14 Rest of Europe Ophthalmic Devices Market Analysis
12.14.1 Pre-COVID-19 Market Scenario
12.14.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Asia-Pacific Ophthalmic Devices Market Analysis
13.1 Asia-Pacific Market Outlook
13.2 Asia-Pacific Market Size Estimation and Forecast
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 Country Market Size Estimation and Forecast
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Asia-Pacific Market Size Estimation and Forecast By Optical Coherence Tomography Type
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Asia-Pacific Market Size Estimation and Forecast By Ophthalmic Diagnostic Devices
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Asia-Pacific Market Size Estimation and Forecast By Type
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Asia-Pacific Market Size Estimation and Forecast By Ophthalmic Surgical Devices
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Asia-Pacific Market Size Estimation and Forecast By End-User
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 China Ophthalmic Devices Market Analysis
13.9.1 Endoart® Has Been Granted The Designation Of Innovative Medical Device By Eyeyon Medical In China.
13.9.2 Bridge Point Capital And China Eye Valley Announced Strategic Partnership
13.9.3 Pre-COVID-19 Market Scenario
13.9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 India Ophthalmic Devices Market Analysis
13.10.1 Ophthalmology-Based Diseases In India Are Increasing
13.10.2 Pre-COVID-19 Market Scenario
13.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 Japan Ophthalmic Devices Market Analysis
13.11.1 Verily Plans Digital Eye Care Joint Venture With Japan's Santen Pharma
13.11.2 Launch Of A New Combination Ophthalmic Solution For The Treatment Of Glaucoma And Ocular Hypertension, AILAMIDE® Combination Ophthalmic Suspension
13.11.3 Pre-COVID-19 Market Scenario
13.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 South Korea Ophthalmic Devices Market Analysis
13.12.1 Santen And Ube Announces Launch Of Glaucoma And Ocular Hypertension Treatment EYBELIS Ophthalmic Solution 0.002% In South Korea
13.12.2 South Korea's MFDS Approves Lumify® Eye Drops
13.12.3 Pre-COVID-19 Market Scenario
13.12.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 Australia Ophthalmic Devices Market Analysis
13.13.1 Australian TGA Approves Glaukos’ PRESERFLO Microshunt
13.13.2 Nova Eye Medical Acquires Key Glaucoma Patents To Drive New Product Expansion
13.13.3 Pre-COVID-19 Market Scenario
13.13.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Rest of Asia-Pacific Ophthalmic Devices Market Analysis
13.14.1 Pre-COVID-19 Market Scenario
13.14.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 LAMEA Ophthalmic Devices Market Analysis
14.1 LAMEA Demand of Medical Devices Will Drive The Market
14.2 LAMEA Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Country Market Size Estimation and Forecast
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 LAMEA Market Size Estimation and Forecast By Optical Coherence Tomography Type
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 LAMEA Market Size Estimation and Forecast By Ophthalmic Diagnostic Devices
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
1.1.1 Analysis)
14.6 LAMEA Market Size Estimation and Forecast By Type
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 LAMEA Market Size Estimation and Forecast By Ophthalmic Surgical Devices
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 LAMEA Market Size Estimation and Forecast By End-User
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Brazil Ophthalmic Devices Market Analysis
14.9.1 Nemera’s Preservative-Free Multi-Dose Eye Dropper Approved In Brazil For Aché’s NSAID’s And Dry Eye Formulations
14.9.2 I-Pen® Osmolarity System Now Available In Brazil Through Partnership With Drycom
14.9.3 Pre-COVID-19 Market Scenario
14.9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 South Africa Ophthalmic Devices Market Analysis
14.10.1 Eyenuk Launches Eyeart AI System In South Africa In Collaboration With Discovery Health
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 Saudi Arabia Ophthalmic Devices Market Analysis
14.11.1 Vision Correction Devices Are Expected To Register A High CAGR During The Forecast Period
14.11.2 Pre-COVID-19 Market Scenario
14.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Turkey Ophthalmic Devices Market Analysis
14.12.1 SIFI Receives Marketing Authorization For Ophthalmic Products In In Turkey
14.12.2 Pre-COVID-19 Market Scenario
14.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 UAE Ophthalmic Devices Market Analysis
14.13.1 Rivoli Vision Announced Strategic Partnership With ZEISS
14.13.2 Pre-COVID-19 Market Scenario
14.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Rest of LAMEA Ophthalmic Devices Market Analysis
14.14.1 Pre-COVID-19 Market Scenario
14.14.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15 Leading Company Profiles
15.1 Alcon
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Company Financial Profile
15.1.4 Company Product Benchmarking
15.1.5 Company Recent Developments
15.2 Johnson & Johnson Vision Care
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Company Financial Profile
15.2.4 Company Product Benchmarking
15.2.5 Company Recent Developments
15.3 HOYA Corporation
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Company Financial Profile
15.3.4 Company Product Benchmarking
15.3.5 Company Recent Developments
15.4 Carl Zeiss Meditec
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Company Financial Profile
15.4.4 Company Product Benchmarking
15.4.5 Company Recent Developments
15.5 Topcon
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Company Financial Profile
15.5.4 Company Product Benchmarking
15.5.5 Company Recent Developments
15.6 Glaukos Corporation
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Company Financial Profile
15.6.4 Company Product Benchmarking
15.6.5 Company Recent Developments
15.7 STAAR Surgical
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Company Financial Profile
15.7.4 Company Product Benchmarking
15.7.5 Company Recent Developments
15.8 Novartis AG
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Company Financial Profile
15.8.4 Company Product Benchmarking
15.8.5 Company Recent Developments
15.9 Bausch Health Companies Inc
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Company Financial Profile
15.9.4 Company Product Benchmarking
15.9.5 Company Recent Developments
15.10 Essilor Luxottica
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Company Financial Profile
15.10.4 Company Product Benchmarking
15.10.5 Company Recent Developments
15.11 Sonomed Escalon
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Company Financial Profile
15.11.4 Company Product Benchmarking
15.12 Cooper Vision Inc
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Company Financial Profile
15.12.4 Company Product Benchmarking
15.12.5 Company Recent Developments
15.13 NIDEK
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Company Product Benchmarking
15.13.4 Company Recent Developments
15.14 Haag-Streit
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Company Product Benchmarking
15.14.4 Company Recent Developments
15.15 Ziemer Ophthalmic Systems
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Company Product Benchmarking
15.15.4 Company Recent Developments
15.16 Lumenis
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Company Product Benchmarking
15.16.4 Company Recent Developments
15.17 OPHTEC BV
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Company Product Benchmarking
15.17.4 Company Recent Developments
15.18 Heine Optotechnik
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Company Product Benchmarking
15.18.4 Company Recent Developments
15.19 Visionix
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Company Product Benchmarking
15.19.4 Company Recent Developments
15.20 Gulden Ophthalmics
15.20.1 Company Snapshot
15.20.2 Company Overview
15.20.3 Company Product Benchmarking
16 Conclusion
16.1 Concluding Remarks
16.2 Recommendations for Market Players
List of Tables
Table 1. Global Ophthalmic Devices Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 2. Global Ophthalmic Devices Market Snapshot, 2022 & 2032 (US$million, CAGR %)
Table 3. Global Ophthalmic Devices Market SWOT Analysis 2022-2032
Table 4. Global Ophthalmic Devices Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 5. Global Ophthalmic Devices Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 6. Global Ophthalmic Devices Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 7. Global Ophthalmic Devices Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 8. Global Ophthalmic Devices Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 9. Global Ophthalmic Devices Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 10. Global Ophthalmic Devices Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 11. Global Ophthalmic Devices Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 12. Global Ophthalmic Devices Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 13. Global Ophthalmic Devices Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 14. Global Ophthalmic Devices Market by Optical Coherence Tomography Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 15. Global Ophthalmic Devices Market by Optical Coherence Tomography Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 16. Global Ophthalmic Devices Market by Optical Coherence Tomography Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 17. Global Ophthalmic Devices Market by Optical Coherence Tomography Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 18. Global Ophthalmic Devices Market by Optical Coherence Tomography Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 19. Global Ophthalmic Devices Market by Ophthalmic Diagnostic Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 20. Global Ophthalmic Devices Market by Ophthalmic Diagnostic Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 21. Global Ophthalmic Devices Market by Ophthalmic Diagnostic Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 22. Global Ophthalmic Devices Market by Ophthalmic Diagnostic Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 23. Global Ophthalmic Devices Market by Ophthalmic Diagnostic Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 24. Global Ophthalmic Devices Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 25. Global Ophthalmic Devices Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 26. Global Ophthalmic Devices Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 27. Global Ophthalmic Devices Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 28. Global Ophthalmic Devices Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 29. Global Ophthalmic Devices Market by Ophthalmic Surgical Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 30. Global Ophthalmic Devices Market by Ophthalmic Surgical Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 31. Global Ophthalmic Devices Market by Ophthalmic Surgical Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 32. Global Ophthalmic Devices Market by Ophthalmic Surgical Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 33. Global Ophthalmic Devices Market by Ophthalmic Surgical Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 34. Global Ophthalmic Devices Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 35. Global Ophthalmic Devices Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 36. Global Ophthalmic Devices Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 37. Global Ophthalmic Devices Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 38. Global Ophthalmic Devices Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 39. North America Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 40. North America Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 41. North America Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 42. North America Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 43. North America Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 44. North America Ophthalmic Devices Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 45. North America Ophthalmic Devices Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 46. North America Ophthalmic Devices Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 47. North America Ophthalmic Devices Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 48. North America Ophthalmic Devices Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 49. North America Ophthalmic Devices Market by Optical Coherence Tomography Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 50. North America Ophthalmic Devices Market by Optical Coherence Tomography Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 51. North America Ophthalmic Devices Market by Optical Coherence Tomography Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 52. North America Ophthalmic Devices Market by Optical Coherence Tomography Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 53. North America Ophthalmic Devices Market by Optical Coherence Tomography Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 54. North America Ophthalmic Devices Market by Ophthalmic Diagnostic Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 55. North America Ophthalmic Devices Market by Ophthalmic Diagnostic Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 56. North America Ophthalmic Devices Market by Ophthalmic Diagnostic Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 57. North America Ophthalmic Devices Market by Ophthalmic Diagnostic Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 58. North America Ophthalmic Devices Market by Ophthalmic Diagnostic Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 59. North America Ophthalmic Devices Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 60. North America Ophthalmic Devices Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 61. North America Ophthalmic Devices Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 62. North America Ophthalmic Devices Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 63. North America Ophthalmic Devices Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 64. North America Ophthalmic Devices Market by Ophthalmic Surgical Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 65. North America Ophthalmic Devices Market by Ophthalmic Surgical Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 66. North America Ophthalmic Devices Market by Ophthalmic Surgical Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 67. North America Ophthalmic Devices Market by Ophthalmic Surgical Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 68. North America Ophthalmic Devices Market by Ophthalmic Surgical Devices, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 69. North America Ophthalmic Devices Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 70. North America Ophthalmic Devices Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 71. North America Ophthalmic Devices Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 72. North America Ophthalmic Devices Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 73. North America Ophthalmic Devices Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 74. US Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 75. US Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 76. US Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 77. US Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 78. US Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 79. Canada Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 80. Canada Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 81. Canada Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 82. Canada Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 83. Canada Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 84. Mexico Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 85. Mexico Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 86. Mexico Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 87. Mexico Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 88. Mexico Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 89. Europe Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 90. Europe Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 91. Europe Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 92. Europe Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 93. Europe Ophthalmic Devices Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 94. Europe Ophthalmic Devices Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 95. Europe Ophthalmic Devices Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 96. Europe Ophthalmic Devices Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 97. Europe Ophthalmic Devices Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Reco
